Get the Stockscreener App
5.96
3.65%
0.21
After Hours:
5.96
Compass Pathways Plc Adr stock is traded at $5.96, with a volume of 2.23M.
It is up +3.65% in the last 24 hours and down -6.73% over the past month.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
See More
Previous Close:
$5.75
Open:
$5.86
24h Volume:
2.23M
Relative Volume:
0.81
Market Cap:
$768.38M
Revenue:
-
Net Income/Loss:
$-287.41M
P/E Ratio:
-1.9514
EPS:
-3.0542
Net Cash Flow:
$-157.61M
1W Performance:
+4.20%
1M Performance:
-6.73%
6M Performance:
-12.74%
1Y Performance:
+97.35%
1-Day Range:
$5.675
$5.98
1-Week Range:
$5.52
$5.98
52-Week Range:
$2.25
$8.90
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Name
Compass Pathways Plc Adr
Sector
Industry
Phone
1-716-676-6461
Address
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
5.96 | 741.31M | 0 | -287.41M | -157.61M | -3.0542 |
HCA
Hca Healthcare Inc
|
488.58 | 111.48B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
193.56 | 17.10B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.84 | 12.68B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
197.92 | 11.59B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
180.15 | 11.10B | 17.36B | 1.51B | 849.25M | 23.15 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-23-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-27-25 | Initiated | Stifel | Buy |
| Jul-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Apr-01-24 | Initiated | Morgan Stanley | Overweight |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Nov-21-22 | Resumed | Berenberg | Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Oct-29-21 | Initiated | Oppenheimer | Outperform |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
| May-11-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-01-21 | Initiated | ROTH Capital | Buy |
| Oct-14-20 | Initiated | H.C. Wainwright | Buy |
| Oct-13-20 | Initiated | Berenberg | Buy |
| Oct-13-20 | Initiated | Canaccord Genuity | Buy |
| Oct-13-20 | Initiated | Cowen | Outperform |
| Oct-13-20 | Initiated | Evercore ISI | Outperform |
View All
Compass Pathways Plc Adr Stock (CMPS) Latest News
Compass Pathways Touts Phase 3 COMP360 Depression Data, Eyes Rolling NDA and 2026 Launch Readiness - Yahoo Finance
Compass Pathways opens grant program for psilocybin training - Investing.com
COMPASS Pathways stock: Why psychedelic therapy potential draws investors now - AD HOC NEWS
Compass Pathways (NASDAQ:CMPS) & Elevance Health (NYSE:ELV) Financial Comparison - Defense World
Compass Pathways PLC Sponsored ADR $CMPS Shares Bought by Hennion & Walsh Asset Management Inc. - MarketBeat
What is HC Wainwright's Estimate for CMPS Q1 Earnings? - MarketBeat
Compass Pathways (NASDAQ:CMPS) Trading 9.7% HigherWhat's Next? - MarketBeat
Compass Pathways (NASDAQ: CMPS) posts pivotal TRD wins and targets 2026 NDA - Stock Titan
Compass Pathways Eyes Rolling FDA Filing for COMP360, Preps TRD Launch Ahead of Q3 Data - Yahoo Finance
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - MarketBeat
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 - Barchart.com
Compass Pathways (NASDAQ:CMPS) Trading Down 6.3%What's Next? - MarketBeat
Compass Pathways (NASDAQ:CMPS) Trading 8.8% HigherWhat's Next? - MarketBeat
Jefferies Financial Group Inc. Invests $7.89 Million in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - Sahm
Compass Pathways Highlights Phase 3 COMP360 TRD Gains, 26-Week Durability and FDA Path at Conference - Yahoo Finance
Why Did Compass Pathways Stock Rocket Higher Today? - AOL.com
Blue Owl Capital Holdings LP Acquires 375,000 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
HC Wainwright Has Positive Outlook of CMPS FY2026 Earnings - Defense World
HC Wainwright Lifts Earnings Estimates for Compass Pathways - MarketBeat
Propel Bio Management LLC Makes New $2.92 Million Investment in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
ARK Investment Management LLC Buys 471,897 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
FY2030 Earnings Forecast for CMPS Issued By HC Wainwright - MarketBeat
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Benzinga
Compass Pathways raises $200M from warrant exercises - Investing.com
Compass Pathways (NASDAQ:CMPS) Stock Price Down 6.9%Here's Why - MarketBeat
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Bitget
Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise - MarketBeat
Cathie Wood’s ARK sells DraftKings stock, buys Figma and Compass Pathways - Investing.com South Africa
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz
Compass Pathways prices $150 million public offering of ADSs By Investing.com - Investing.com South Africa
Compass Pathways prices $150 million public offering of ADSs - Investing.com
Compass Pathways announces $150 million ADS offering - Investing.com India
Rezolve AI PLC (NASDAQ:RZLV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Mister Car Wash, Inc. (NYSE:MCW) Given Consensus Rating of “Hold” by Analysts - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Compass Pathways announces $150 million ADS offering By Investing.com - Investing.com UK
COMPASS Pathways touts Phase III psilocybin wins in TRD, eyes FDA NDA and expedited review - Yahoo Finance
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Compass Pathways stock soars after positive Phase 3 trial results By Investing.com - Investing.com India
Compass Pathways stock soars after positive Phase 3 trial results - Investing.com
Compass Pathways reports positive phase 3 results for depression drug - Investing.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - Defense World
Compass Pathways to release new clinical data on psilocybin trials - Investing.com India
Compass Pathways to release new clinical data on psilocybin trials By Investing.com - Investing.com South Africa
Compass Pathways Plc Adr Stock (CMPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.58%
3.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):